Effect of Celery Powder on Diabetes Control

The Effect of Celery Powder on Glycemic Control, Lipid Profile and Weight in Obese Individuals with Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100223003408N8

Enrollment

Registered

2021-03-01

Start date

2021-02-19

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Mellitus. Type 2 diabetes mellitus without complications

Interventions

Intervention 1: Participants in the intervention group will receive three capsules of celery powder (produced from stalks and leaf)with a dose of 250 mg (overall 750 mg) daily for 12 weeks. During the

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Overweight and obese adults with BMI between 25 to 40 Suffering from Type 2 diabetes mellitus using oral medications Suffering from hyperlipidemia using oral medications Aged 20 to 60 years Willingness of participating Not using slimming medication for 3 months prior to the study Absence of thyroid, kidney, liver or cardiovascular diseases Absence of metabolic (except type 2 diabetes), endocrine or congenital disorders

Exclusion criteria

Exclusion criteria: Undergoing slimming, gastric bypass surgery Participating in other clinical trials Being pregnant or in lactation period

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.	—

Secondary

Measure	Time frame
Weight. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Scale - kg.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;Serum total cholesterol. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;Low density lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;High-density lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;MDA. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;ALT. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;AST. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.	—

Measure

Time frame

Weight. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Scale - kg.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;Serum total cholesterol. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;Low density lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;High-density lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;MDA. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;ALT. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.;AST. Timepoint: At the beginning of the study (before the intervention) and 3 months after the start of intervention. Method of measurement: Standard enzymatic method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Ekramzade

Shiraz University of Medical Sciences

ekramzadeh@sums.ac.ir+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026